Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D-Ala-D-Ala-containing peptidoglycan precursor is a key molecular structure in bacterial cell wall biosynthesis. It refers specifically to the terminal dipeptide sequence (D-alanyl-D-alanine) found at the end of the pentapeptide stem attached to N-acetylmuramic acid (MurNAc) within peptidoglycan precursors, such as Lipid II. This motif is essential for cross-linking reactions that provide strength and rigidity to bacterial cell walls, and is a target for several antibiotics.
Inhibition of cell wall synthesis by preventing cross-linking of peptidoglycan
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-Alanyl-D-Alanine-containing Peptidoglycan Precursor.